GlassScriptPhysician profile
Suman Pasupuleti
NPI 1851503809
$57,511.62
in general payments reported to CMS, 2019-2025
38 companies · $3,119 in 2025
The $3,119 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25K · 2020: $9,006 · 2021: $7,307 · 2022: $2,966 · 2023: $5,427 · 2024: $4,206 · 2025: $3,119.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,000 · Food and Beverage: $3,752.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,000.00 |
| Food and Beverage | $3,751.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $22,228.20 | 2019-2025 | Lifevest |
| Janssen Pharmaceuticals, INC | $11,154.10 | 2019-2024 | Xarelto |
| Astrazeneca Pharmaceuticals LP | $9,696.73 | 2019-2025 | Farxiga, Brilinta, Lokelma |
| Abbott Laboratories | $9,568.67 | 2019-2024 | Thoratec Heartmate 3 Lvas Implant Kit, Jot Dx |
| Medtronic, INC. | $1,543.14 | 2021-2025 | Micra, Linq II, Cobalt Dr Mri Surescan |
| Impulse Dynamics (USA) INC. | $390.37 | 2022-2025 | Optimizer, Optimizer |
| Biosense Webster, INC. | $240.08 | 2019-2023 | Carto 3 |
| Medtronic Vascular, INC. | $224.47 | 2019-2020 | |
| Pfizer INC. | $223.12 | 2019-2025 | |
| Amgen INC. | $221.62 | 2019-2025 | Repatha |
| Alnylam Pharmaceuticals INC. | $202.27 | 2024-2025 | Onpattro, Amvuttra |
| E.R. Squibb & Sons, L.L.C. | $190.57 | 2019-2025 | Eliquis, Camzyos |
| Boston Scientific Corporation | $142.22 | 2021-2025 | Watchman Flx |
| Edwards Lifesciences Corporation | $135.71 | 2025 | |
| Nuwellis, INC. | $129.67 | 2019-2021 |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $127.66 | 2020-2025 | Nexletol |
| Tesaro, INC. | $124.99 | 2019 | |
| Novartis Pharmaceuticals Corporation | $118.05 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $117.80 | 2022-2025 | Verquvo |
| Amarin Pharma, INC. | $83.64 | 2020-2021 | |
| Kestra Medical Technology Services, INC. | $83.24 | 2023-2025 | Assure Wcd |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.89 | 2025 | Jardiance |
| Novo Nordisk INC | $77.73 | 2022-2024 | Ozempic, Rybelsus |
| Zoll Circulation INC | $51.66 | 2020 | |
| Bardy Diagnostics, INC. | $40.50 | 2020-2021 | |
| Lexicon Pharmaceuticals, INC. | $38.27 | 2023-2024 | Inpefa |
| Welch Allyn | $38.13 | 2021 | |
| Sanofi-Aventis U.S. LLC | $34.81 | 2019-2024 | |
| Inari Medical, INC. | $29.45 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Teleflex LLC | $28.85 | 2019-2022 | |
| Biotronik INC. | $27.77 | 2024 | Biomonitor |
| Genzyme Corporation | $21.15 | 2023 | |
| Bayer Healthcare Pharmaceuticals INC. | $18.75 | 2025 | |
| Innovation Technologies INC | $16.91 | 2025 | Irrisept |
| Astellas Pharma US INC | $15.95 | 2019 | |
| Cardiva Medical, INC. | $15.59 | 2021 | |
| Atricure, INC. | $15.17 | 2019 | |
| Cvrx, INC. | $12.72 | 2024 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suman Pasupuleti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.